Abstract
Background
Optimizing post-discharge medication adherence is a target for avoiding adverse events. Nevertheless, few studies have focused on predictors of post-discharge medication adherence.
Methods
The Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study used counseling and follow-up to improve post-discharge medication safety. In this secondary data analysis, we analyzed predictors of self-reported medication adherence after discharge. Based on an interview at 30 days post-discharge, an adherence score was calculated as the mean adherence in the previous week of all regularly scheduled medications. Multivariable linear regression was used to determine the independent predictors of post-discharge adherence.
Results
The mean age of the 646 included patients was 61.2 years, and they were prescribed an average of 8 daily medications. The mean post-discharge adherence score was 95% (SD = 10.2%). For every 10 year increase in age, there was a 1% absolute increase in post-discharge adherence (95% CI 0.4% −2.0%). Compared to patients with private insurance, patients with Medicaid were 4.5% less adherent (95% CI −7.6% to −1.4%). For every 1-point increase in baseline medication adherence score, as measured by the 4-item Morisky score, there was a 1.6% absolute increase in post-discharge medication adherence (95% CI 0.8% to 2.4%). Surprisingly, health literacy was not an independent predictor of post-discharge adherence.
Conclusions
In patients hospitalized for cardiovascular disease, predictors of lower medication adherence post-discharge included younger age, Medicaid insurance, and baseline non-adherence. These factors can help predict patients who may benefit from further interventions.
Background
In the outpatient setting, medication adherence (defined as percentage of prescribed medication doses taken by a patient during a specific time period) ranges between 40 and 80 percent for chronic conditions. 1 During acute care hospitalization, changes are often made to patients’ medication regimens, which can be confusing and contribute to non-adherence, medication errors, and harmful adverse events. 2 Indeed it is estimated that almost half of patients encounter a medication error after discharge, and approximately 12–17% experience an adverse drug event after returning home. 3–6 It is likely that some of these adverse events may be the result of medication non-adherence. 7 Improved patient-provider communication, systems to reconcile pre- and post-hospitalization medications, as well as development of mechanisms to enhance adherence may prevent many of these errors and have become new targets for quality improvement. 4, 8 Although post-discharge medication adherence is a crucial target for avoiding adverse events and re-hospitalization, few studies have focused on understanding its incidence and predictors, in particular patient demographic factors such as age and insurance status. 9–11
In addition, few studies have looked at general and post-hospital adherence in a population where health literacy is measured, an important area because medication changes during hospitalization may be particularly confusing for patients with low health literacy. 11, 12 Health literacy is defined as “the degree to which an individual has the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions.”13 Prior outpatient research shows that low health literacy is associated with poor patient understanding of the medication regimen and instructions for medication use, which may contribute to post-discharge medication non-adherence.14, 15 Understanding the factors associated with post-discharge medication adherence could help refine interventions that are oriented toward improving transitions in care, patient safety, and reducing unnecessary re-hospitalization.
We report here on factors associated with post-discharge medication adherence using data from the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study. 16
Methods
Study and Participants
PILL-CVD was a federally-funded, two-site randomized controlled trial using pharmacist-assisted medication reconciliation, inpatient pharmacist counseling, low-literacy adherence aids, and telephone follow-up that aimed to decrease rates of serious medication errors after hospital discharge. 16 The study targeted patients with cardiovascular disease (hospitalized on cardiology or general medical or geriatric services for acute coronary syndromes [ACS] or acute decompensated heart failure [ADHF]) at two large academic hospitals, Brigham and Women’s Hospital (BWH) and Vanderbilt University Hospital (VUH).
Subjects were eligible for enrollment if they met criteria for ACS or ADHF, were likely to be discharged to home as determined by the primary medical team at the time of study enrollment, and took primary responsibility for administering their medications prior to admission (caregivers could be involved in medication management after discharge). Exclusion criteria included severe visual or hearing impairment, inability to communicate in English or Spanish, active psychiatric illness, dementia, delirium, illness too severe to participate, lack of a home phone number, being in police custody, or participation in another intensive medication adherence program (e.g., due to renal transplant).
Out of 6416 patients originally screened for possible enrollment, 862 were randomly assigned to receive usual care or usual care plus the intervention, and 851 remained in the study.16 Both the main study and this secondary data analysis were approved by the Institutional Review Boards of each site.
Baseline measures
Following informed consent and study enrollment, a variety of baseline data were collected on study participants from medical records and patient interview, including primary language, demographic information (age, race, insurance status, income, and education level), cognition (through administration of the 0–5 point MiniCog scale) 17 and level of health literacy (through use of the 0–36 point short form of the Test of Functional Health Literacy in Adults, s-TOFHLA scale). 18 Baseline information was also collected on medication use, including number of preadmission medications, measurement of self-reported adherence prior to admission (using the Morisky scale, a validated 0–4 point questionnaire shown to correlate with disease control and indicative of general patterns of adherence), 19 and a medication understanding score, adapted from other instruments, which quantifies understanding of the indication, dose, and frequency of up to 5 randomly selected preadmission medications on a 0–3 point scale. 16,20, 21
Outcome measures
Outcomes were collected 30 days post-discharge through a structured questionnaire, administered by telephone. Only patients who completed this call are included in the present analysis. Post-discharge medication adherence was assessed by asking patients to report the number of days out of the previous week they had taken each medication from their post-discharge regimen exactly as prescribed.22 A score was calculated for each medication as the proportion of adherent days (e.g., if a patient reported missing 2 days of a medication in the previous week, then adherence would be 5/7 or 71%). A global post-discharge adherence score was then derived for each patient by averaging the adherence score for all regularly-scheduled medications. This quantitative measure focused on adherence to medications patients knew they should be taking and did not measure medication discrepancies (sometimes termed “unintentional non-adherence”).
Analysis
Patient characteristics were summarized and reported using simple descriptive statistics. Candidate predictors of post-discharge medication adherence were chosen a priori from patient characteristics assessed during hospital admission. These included patient age, gender, race, ethnicity, marital status, insurance, years of education, presence of PCP, study site, number of preadmission medications, medication understanding, baseline adherence, cognition, and health literacy. Unadjusted results were calculated using univariable linear regression with each patient’s adherence score as the dependent variable and each predictor as the independent variable. Adjusted results were then derived using multivariable linear regression with all the candidate predictors in the model.
Lastly, because of missing data for some predictors, in particular baseline adherence and medication understanding, multiple imputation techniques were used to impute missing data and increase statistical power. 23 We used the Markov Chain Monte Carlo (MCMC) method for multiple imputation, which generally assumes that the data came from a normal distribution and that the missing data are missing at random. Because of the essentially normal distribution of the data, and because the amount of missing data was so small (<1% for almost all variables, 5% for baseline adherence, and 8% for medication understanding), we expected little bias and present the complete case analysis, which maximized statistical power.
Two-sided p values < 0.05 were considered significant, and SAS version 9.2 (Cary, NC) was used for all analyses.
Results
Table 1 shows descriptive baseline patient characteristics of study sample (responders) as well as non-responders at 30 days. For the responders, the mean age of the 646 patients was 61.2 years, 94.7% were insured, and 19.3% had inadequate or marginal health literacy. Patients were prescribed an average of 8 preadmission medications. Most patients (92.3%) had a regular primary care physician prior to admission. Non-responders had non-significant trends towards having lower health literacy, medication understanding, and baseline medication adherence.
Table 1.
Characteristic | Total N, 30 day respondents | Value | Total N, nonrespondents | Value |
---|---|---|---|---|
| ||||
Age, mean in years (SD) | 646 | 61.2 (13.5) | 45 | 55.4 (14.3) |
| ||||
Gender, N (percentage) | 646 | 45 | ||
- Female | 272 (42.1) | 18 (40.0) | ||
- Male | 374 (57.9) | 27 (60.0) | ||
| ||||
Race, N (percentage) | 643 | 45 | ||
- White | 511 (79.5) | 32 (71.1) | ||
- Black | 104 (16.2) | 11 (24.4) | ||
- Other | 28 (4.4) | 2 (4.4) | ||
| ||||
Ethnicity, N (percentage) | 639 | 45 | ||
- Hispanic | 24 (3.8) | 1 (2.2) | ||
- Not Hispanic | 615 (96.2) | 44 (97.8) | ||
| ||||
Marital status, N (percentage) | 646 | 45 | ||
- Married/cohabitate | 382 (59.1) | 20 (44.4) | ||
- Separated/divorced | 118 (18.3) | 11 (24.4) | ||
- Widowed | 81 (12.5) | 5 (11.1) | ||
- Never married | 65 (10.1) | 9 (2.0) | ||
| ||||
Insurance type, N (percentage) | 646 | 45 | ||
- Medicaid | 53 (8.2) | 5 (11.1) | ||
- Medicare | 270 (41.8) | 13 (28.9) | ||
- Private | 289 (44.7) | 19 (42.2) | ||
- Self-pay | 34 (5.3) | 8 (17.8) | ||
| ||||
Years of education, mean in years (SD) | 643 | 14.0 (3.1) | 45 | 13.3 (2.7) |
| ||||
Presence of PCP prior to admission, N (percentage) | 646 | 45 | ||
- Yes | 596 (92.3) | 38 (84.4) | ||
- No | 50 (7.74) | 7 (15.6) | ||
| ||||
Site, N (percentage) | 646 | 45 | ||
- Site 1 | 358 (55.4) | 8 (17.8) | ||
- Site 2 | 288 (44.6) | 37 (82.2) | ||
| ||||
Number of preadmission medications, mean number (SD) | 641 | 7.8 (4.8) | 45 | 7.7 (5.4) |
| ||||
Medication Understanding Score, mean (SD)* | 597 | 2.4 (0.5) | 40 | 2.2 (0.62) |
| ||||
Health Literacy (STOFHLA) score, mean (SD)† | 642 | 29.1 (8.9) | 45 | 26.0 (12.0) |
| ||||
Baseline adherence (SD)‡ | 613 | 2.7 (1.1) | 45 | 2.4 (1.2) |
| ||||
Minicog score, N (percentage)|| | 646 | 45 | ||
- Demented | 63 (9.8) | 5 (11.1) | ||
- Not demented | 583 (90.2) | 40 (88.9) |
0–3, with 3 indicating better understanding
0–36, with higher scores indicating higher health literacy
0–4, with 4 indicating higher baseline adherence
0–5, with higher scores indicating better cognition. A score < 3indicates dementia
The average post-discharge adherence score was 95% (SD = 10.2%), and less than 10% of patients had an adherence score of less than 85%; overall the distribution was left-skewed. Table 2 illustrates crude and adjusted parameter estimates for variables in the model. Table 3 shows significant findings in the fully adjusted model, which used multiple imputation techniques to account for missing data.
Table 2.
Predictor | Crude parameter estimate (beta) with 95% confidence intervals | P value | Adjusted parameter estimate (beta) with 95% confidence intervals | P value |
---|---|---|---|---|
| ||||
Age per 10 years | 0.010 (0.007–0.020) | <0.0001 | 0.010 (0.002, 0.020) | 0.018 |
| ||||
Male gender | 0.012 (−0.004, 0.028) | 0.137 | 0.003 (−0.014, 0.020) | 0.727 |
| ||||
Race/ethnicity | ||||
- White | 0.011 (−0.009, 0.031) | 0.266 | Ref | Ref |
- Black | −0.017 (−0.038, 0.005) | 0.13 | 0.006 (−0.017, 0.030) | 0.598 |
- Other | 0.010 (−0.029, 0.049) | 0.599 | 0.017 (−0.027, 0.062) | 0.446 |
| ||||
Hispanic/Latino | 0.005 (−0.037, 0.047) | 0.803 | 0.036 (−0.013, 0.085) | 0.149 |
| ||||
Marital status | ||||
- Married/cohabitate | 0.006 (−0.011, 0.022) | 0.500 | Ref | Ref |
- Separated/divorced | −0.005 (−0.025, 0.016) | 0.664 | 0.009 (−0.014, 0.031) | 0.446 |
- Widowed | 0.001 (−0.023, 0.025) | 0.922 | −0.013 (−0.039, 0.013) | 0.338 |
- Never married | −0.009 (−0.035, 0.018) | 0.515 | −0.004 (−0.033, 0.025) | 0.784 |
| ||||
Insurance type | ||||
- Private | 0.008 (−0.008, 0.024) | 0.347 | Ref | Ref |
- Medicaid | −0.046 (−0.075, −0.018) | 0.002 | −0.026 (−0.058, 0.007) | 0.121 |
- Medicare | 0.012 (−0.004, 0.028) | 0.138 | −0.002 (−0.023, 0.018) | 0.844 |
- Self-pay | −0.027 (−0.062, 0.008) | 0.135 | −0.029 (−0.073, 0.015) | 0.202 |
| ||||
Years of education | 0.003 (0.0003, 0.005) | 0.028 | 0.0001 (−0.003, 0.003) | 0.949 |
| ||||
Presence of PCP prior to admission | 0.007 (−0.022, 0.037) | 0.630 | 0.002 (−0.032, 0.036) | 0.888 |
| ||||
Site | −0.050 (−0.065, −0.034) | <0.0001 | −0.038 (−0.056, −0.021) | <0.0001 |
| ||||
Number of preadmission medications | −0.0003 (−0.002, 0.001) | 0.684 | −0.0001 (−0.002, 0.002) | 0.918 |
| ||||
Med understanding score per point | 0.007 (−0.009, 0.023) | 0.390 | 0.006 (−0.011, 0.023) | 0.513 |
| ||||
Health literacy (STOFHLA) score per 10 points | 0.0006 (−0.008, 0.01) | 0.897 | 0.003 (−0.008, 0.01) | 0.644 |
| ||||
Baseline adherence per point | 0.023 (0.016, 0.031) | <0.0001 | 0.017 (0.009, 0.024) | <0.0001 |
| ||||
Cognitive function | 0.004 (−0.022, 0.031) | 0.757 | 0.008 (−0.019, 0.036) | 0.549 |
• For crude estimates, value is category versus absence of parameter in bivariate testing
• For adjusted estimates of categorical variables, value is each category compared to referent category
• Beta-coefficient represents absolute change in adherence (e.g., 0.010 for age means a 1% absolute increase in adherence for every 10 year increase in patient age)
Table 3.
Predictor | Parameter estimate (beta) with 95% confidence intervals | P value |
---|---|---|
| ||
Age per 10 years | 0.010 (0.004, 0.020) | 0.004 |
| ||
Insurance type | ||
- Private | Ref | Ref |
- Medicaid | −0.045 (−0.076, −0.014) | 0.005 |
- Medicare | −0.010 (−0.030, 0.010) | 0.333 |
- Self-pay | −0.013 (−0.050, 0.025) | 0.512 |
| ||
Site | −0.036 (−0.053, −0.019) | <0.0001 |
| ||
Baseline adherence per point | 0.016 (0.008, 0.024) | <0.0001 |
• Total observations 646; 67 with missing values
• All variables adjusted for gender, race, cognitive function, number of preadmission medications, marital status, health literacy score, medication understanding score, presence of PCP, years of school, Hispanic/Latino ethnicity.
Intervention arm was of borderline statistical significance in predicting post-discharge adherence (p=0.052), and so was removed from the final model. Study site, age, insurance, and baseline adherence were the only significant independent predictors of post-discharge adherence in the fully adjusted model (Table 3). For example, for every 10 year increase in age, patients had, on average, an adjusted 1% absolute increase in their adherence score (95% CI 0.4% to 2.0%). For every 1-point increase in baseline medication adherence (based on the Morisky scale), there was a 1.6% absolute increase in medication adherence (95% CI 0.8% to 2.4%). In unadjusted analyses, patients with Medicaid were less adherent with medications after discharge than were patients with private insurance. This difference became non-significant in adjusted analyses, but when analyses were repeated using multiple imputation techniques, the results again became statistically significant – Medicaid insurance was associated with a 4.5% absolute decrease in post-discharge adherence compared with private insurance (95% CI −7.6% to −1.4%). Study site (specifically, Brigham and Women’s Hospital) was also a significant predictor of greater post-discharge medication adherence. Years of education was a significant predictor of adherence in unadjusted analyses but was not an independent predictor when adjusted for other factors. When baseline adherence was removed from the multiple imputation model, there were no changes in which factors were significant predictors of adherence.
Discussion
In this study, we found that low baseline adherence, younger age, Medicaid insurance, and study site were significant predictors of lower 30-day medication adherence. Of particular interest is our finding regarding baseline adherence, a simple measure to obtain on hospitalized patients. It is notable that in our study, education was not an independent significant predictor of post-discharge adherence, even when baseline adherence was removed from the model. The same is true for medication understanding, cognitive function, and health literacy.
Older patients appeared more adherent with medications in the month after hospital discharge, perhaps reflecting increased interaction with the healthcare system (appointments, number of physician interactions), a greater belief in the importance of chronic medication management, or a higher level of experience with managing medications. A similar relationship between age and adherence has been shown in outpatient studies of patients with hypertension, diabetes, and other chronic diseases. 24–27
Medicaid patients may be less likely to remain adherent because of the plan’s limited coverage of medications relative to patients’ ability to pay. For example, Medicaid in Tennessee covers the first 5 generic medications at no cost to the patient but has copayments for additional medications and for brand name drugs. Medicaid in Massachusetts has copayments of $1 to $3 for each medication. Alternatively, Medicaid insurance may be a marker for other patient characteristics associated with low adherence for which we were not fully able to adjust.
Site differences were also notable in this study; these differences could have been due to differences in insurance coverage in Tennessee vs. Massachusetts (which has near-universal coverage), differences in types of insurance (e.g., fewer patients at Brigham and Women’s Hospital had Medicaid than at Vanderbilt), cultural and geographic differences between the two locations, or other differences in transitional care between the two sites.
This study corroborates previous literature on medication adherence (specifically unintentional non-adherence) in the outpatient setting, 4, 8–11 for example on the association of younger age with low adherence in certain populations. On the other hand, it may contrast with previous literature which has sometimes shown a relationship between patient education or health literacy and medication adherence. 14, 15, 28–35 However, previous studies have not focused on the transition from inpatient to outpatient settings. Perhaps intensive medication education in the hospital, even under usual care, mitigates the effects of these factors on post-discharge adherence. Finally, baseline adherence seems to correlate with post-discharge adherence, a finding which makes intuitive sense and has been previously reported for specific medications.36
There are several limitations to this study. Although large, the study was performed at only two clinical sites where most patients were white and fairly well-educated, perhaps because patients admitted to a tertiary care center with ACS or ADHF are more affluent than general medical inpatients as a whole; this may limit generalizability. Post-discharge medication adherence might have been higher than in other patient populations given the nature of the population, possible loss-to-follow-up bias, and the fact that half of the subjects received an intervention designed to improve medication management after discharge; such low rates of non-adherence in our study may have reduced our ability to detect important predictors in our models. In addition, the period of follow-up was 30 days, thus limiting our findings to short-term post-discharge medication adherence. Post-discharge medication adherence was based on patient self-report, which not only assumed that the patient was still managing his/her own medications after discharge, but may also be susceptible to both recall and social acceptability bias, which might overestimate our adherence scores, again limiting our ability to detect important predictors of non-adherence. However, other studies have shown a good correlation between self-reported medication adherence and other more objective measures 37, 38 and recall was only for 7 days, a measure used previously in the literature39, 40 and one designed to reduce recall bias. Systematic under-reporting in certain patient populations is less likely but possible.
In the future, research should focus on targeting patients who have low baseline adherence to evaluate the effects of various interventions on post-discharge medication outcomes. Repeating the study in a population with a high prevalence of low health literacy might be illuminating given that previous studies have shown that patients with low health literacy have less ability to identify their medications and have less refill adherence. 29, 30
In conclusion, in patients hospitalized with cardiovascular disease, predictors of lower post-discharge adherence include younger age, Medicaid insurance, and low baseline adherence. It may be prudent to assess baseline adherence and insurance type in hospitalized patients in order to identify those who may benefit from additional assistance to improve medication adherence and medication safety during transitions in care.
Acknowledgments
Dr. Schnipper had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Footnotes
Financial Disclosure: Supported by R01 HL089755 (NHLBI, Kripalani), K23 HL077597 (NHLBI, Kripalani), K08 HL072806 (NHLBI, Schnipper), T32HP10251-02 (Cohen), and by the Division of General Medicine, Massachusetts General Hospital and the Harvard Medical School Fellowship in General Medicine and Primary Care (Cohen).
Conflict of Interest Disclosure: Dr. Kripalani is a consultant to and holds equity in PictureRx, LLC, which makes patient education tools to improve medication management. PictureRx did not provide materials or funding for this study.
Meeting Presentations:
SGIM New England Regional Meeting, oral presentation, Boston, MA, March 4, 2011
SGIM National Meeting, poster presentation, Phoenix, AZ, May 6, 2011
Contributor Information
Marya J. Cohen, Massachusetts General Hospital, Harvard Medical School.
Shimon Shaykevich, Brigham and Women’s Hospital.
Courtney Cawthon, Vanderbilt Center for Health Services Research.
Sunil Kripalani, Section of Hospital Medicine, Division of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University; Vanderbilt Center for Health Services Research
Michael K. Paasche-Orlow, Boston Medical Center, Boston University School of Medicine.
Jeffrey L. Schnipper, BWH Hospitalist Service and Division of General Medicine, Brigham and Women’s Hospital, Harvard Medical School.
References
- 1.Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487–497. doi: 10.1056/NEJMra050100. [DOI] [PubMed] [Google Scholar]
- 2.Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005 Sep 12;165(16):1842–1847. doi: 10.1001/archinte.165.16.1842. [DOI] [PubMed] [Google Scholar]
- 3.Cua YM, Kripalani S. Medication use in the transition from hospital to home. Ann Acad Med Singapore. 2008 Feb;37(2):136–136. [PMC free article] [PubMed] [Google Scholar]
- 4.Moore C, Wisnivesky J, Williams S, McGinn T. Medical errors related to discontinuity of care from an inpatient to an outpatient setting. J Gen Intern Med. 2003 Aug;18(8):646–651. doi: 10.1046/j.1525-1497.2003.20722.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003 Feb 4;138(3):161–167. doi: 10.7326/0003-4819-138-3-200302040-00007. [DOI] [PubMed] [Google Scholar]
- 6.Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. Adverse drug events occurring following hospital discharge. J Gen Intern Med. 2005 Apr;20(4):317–323. doi: 10.1111/j.1525-1497.2005.30390.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006 Mar 13;166(5):565–571. doi: 10.1001/archinte.166.5.565. [DOI] [PubMed] [Google Scholar]
- 8.Vira T, Colquhoun M, Etchells E. Reconcilable differences: correcting medication errors at hospital admission and discharge. Qual Saf Health Care. 2006 Apr;15(2):122–126. doi: 10.1136/qshc.2005.015347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Hassan M, Lage MJ. Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. Am J Health Syst Pharm. 2009 Feb 15;66(4):358–365. doi: 10.2146/ajhp080374. [DOI] [PubMed] [Google Scholar]
- 10.Mansur N, Weiss A, Hoffman A, Gruenewald T, Beloosesky Y. Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study. Drugs Aging. 2008;25(10):861–870. doi: 10.2165/00002512-200825100-00005. [DOI] [PubMed] [Google Scholar]
- 11.Kripalani S, Henderson LE, Jacobson TA, Vaccarino V. Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. Mayo Clin Proc. 2008 May;83(5):529–535. doi: 10.4065/83.5.529. [DOI] [PubMed] [Google Scholar]
- 12.Lindquist LA, Go L, Fleisher J, Jain N, Friesema E, Baker DW. Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge medications. J Gen Intern Med. Feb;27(2):173–178. doi: 10.1007/s11606-011-1886-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. [Accessed February 15, 2012]; http://www.healthypeople.gov/Document/pdf/uih/2010uih.pdf.
- 14.Davis TC, Wolf MS, Bass PF, 3rd, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006 Dec 19;145(12):887–894. doi: 10.7326/0003-4819-145-12-200612190-00144. [DOI] [PubMed] [Google Scholar]
- 15.Kripalani S, Henderson LE, Chiu EY, Robertson R, Kolm P, Jacobson TA. Predictors of medication self-management skill in a low-literacy population. J Gen Intern Med. 2006 Aug;21(8):852–856. doi: 10.1111/j.1525-1497.2006.00536.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Schnipper JL, et al. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study. Circ Cardiovasc Qual Outcomes. 2010;3(2):212–219. doi: 10.1161/CIRCOUTCOMES.109.921833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Borson S, Scanlan JM, Watanabe J, Tu SP, Lessig M. Simplifying detection of cognitive impairment: comparison of the Mini-Cog and Mini-Mental State Examination in a multiethnic sample. J Am Geriatr Soc. 2005 May;53(5):871–874. doi: 10.1111/j.1532-5415.2005.53269.x. [DOI] [PubMed] [Google Scholar]
- 18.Nurss JR. Short Test of Functional Health Literacy in Adults. Snow Camp, NC: Peppercorn Books and Press; 1998. [Google Scholar]
- 19.Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008 May;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 20.Marvanova MRC, Eden SK, Cawthon C, Schnipper JL, Kripalani S. Health literacy and medication understanding among hospitalized adults. J Hosp Med. doi: 10.1002/jhm.998. In press currently. [DOI] [PubMed] [Google Scholar]
- 21.Marvanova M, Roumie CL, Eden SK, Cawthon C, Schnipper JL, Kripalani S. Health literacy and medication understanding among hospitalized adults. J Hosp Med. Nov;6(9):487. doi: 10.1002/jhm.998. [DOI] [PubMed] [Google Scholar]
- 22.Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000 Jul;23(7):943–950. doi: 10.2337/diacare.23.7.943. [DOI] [PubMed] [Google Scholar]
- 23.Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley and Sons, Inc; 1987. [Google Scholar]
- 24.Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004 Jan 1;18(Suppl 1):S19–25. doi: 10.1097/00002030-200418001-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Wong MC, Jiang JY, Griffiths SM. Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study. J Epidemiol Community Health. Oct;64(10):895–901. doi: 10.1136/jech.2009.091603. [DOI] [PubMed] [Google Scholar]
- 26.Wong MC, Kong AP, So WY, Jiang JY, Chan JC, Griffiths SM. Adherence to Oral Hypoglycemic Agents in 26 782 Chinese Patients: A Cohort Study. J Clin Pharmacol. Nov 23; doi: 10.1177/0091270010382911. [DOI] [PubMed] [Google Scholar]
- 27.Gazmararian J, Jacobson KL, Pan Y, Schmotzer B, Kripalani S. Effect of a pharmacy-based health literacy intervention and patient characteristics on medication refill adherence in an urban health system. Ann Pharmacother. Jan;44(1):80–87. doi: 10.1345/aph.1M328. [DOI] [PubMed] [Google Scholar]
- 28.Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999 May;14(5):267–273. doi: 10.1046/j.1525-1497.1999.00334.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med. 2006 Dec;21(12):1215–1221. doi: 10.1111/j.1525-1497.2006.00591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Persell SD, Osborn CY, Richard R, Skripkauskas S, Wolf MS. Limited health literacy is a barrier to medication reconciliation in ambulatory care. J Gen Intern Med. 2007 Nov;22(11):1523–1526. doi: 10.1007/s11606-007-0334-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Chew LD, Bradley KA, Flum DR, Cornia PB, Koepsell TD. The impact of low health literacy on surgical practice. Am J Surg. 2004 Sep;188(3):250–253. doi: 10.1016/j.amjsurg.2004.04.005. [DOI] [PubMed] [Google Scholar]
- 32.Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009 Apr 1;66(7):657–664. doi: 10.2146/ajhp080064. [DOI] [PubMed] [Google Scholar]
- 33.Fang MC, Machtinger EL, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med. 2006 Aug;21(8):841–846. doi: 10.1111/j.1525-1497.2006.00537.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Paasche-Orlow MK, Cheng DM, Palepu A, Meli S, Faber V, Samet JH. Health literacy, antiretroviral adherence, and HIV-RNA suppression: a longitudinal perspective. J Gen Intern Med. 2006 Aug;21(8):835–840. doi: 10.1111/j.1525-1497.2006.00527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Platt AB, Localio AR, Brensinger CM, et al. Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf. 2008 Sep;17(9):853–860. doi: 10.1002/pds.1556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Muntner P, Mann DM, Woodward M, et al. Predictors of low clopidogrel adherence following percutaneous coronary intervention. Am J Cardiol. Sep 15;108(6):822–827. doi: 10.1016/j.amjcard.2011.04.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 8:99. doi: 10.1186/1477-7525-8-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Shi L, Liu J, Koleva Y, Fonseca V, Kalsekar A, Pawaskar M. Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices. Pharmacoeconomics. Dec 1;28(12):1097–1107. doi: 10.2165/11537400-000000000-00000. [DOI] [PubMed] [Google Scholar]
- 39.Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003 May;26(5):1408–1412. doi: 10.2337/diacare.26.5.1408. [DOI] [PubMed] [Google Scholar]
- 40.Grant RW, Devita NG, Singer DE, Meigs JB. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003 Jul-Aug;37(7–8):962–969. doi: 10.1345/aph.1C452. [DOI] [PubMed] [Google Scholar]